• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟哌啶醇在5%葡萄糖注射液中的稳定性。

Stability of haloperidol in 5% dextrose injection.

作者信息

Das Gupta V, Stewart K R

出版信息

Am J Hosp Pharm. 1982 Feb;39(2):292-4.

PMID:7058800
Abstract

The stability of haloperidol in 5% dextrose injection using a high-pressure liquid chromatographic (HPLC) method is reported. A solution of haloperidol 10 mg/dl in 5% dextrose injection was prepared using commercially available haloperidol injection. The solution was stored at 24 degrees C, half in an amber glass bottle and half in a plastic bag. These were assayed on days 0, 1, 7, 14, and 38. Solutions prepared from commercial dosage forms of haloperidol (injection, oral liquid concentrate, and tablets) were assayed to verify the accuracy of the HPLC assay to quantify haloperidol. There was no loss of haloperidol potency in 38 days when stored 24 degrees C in either the amber glass bottle or plastic bag. There was a substantial loss of methylparaben and propylparaben (present in commercial haloperidol injection) in the solution stored in the plastic bag. Oxidation products of haloperidol did not interfere with the assay, and the HPLC assay accurately measured haloperidol in solutions prepared from commercial dosage forms. The results show that haloperidol 10 mg/dl in 5% dextrose injection was stable for at least 38 days. While the loss of parabens is not of practical importance, the HPLC method developed provided this information while the previously used USP-NF procedure did not. The assay can be used to quantify haloperidol in commercial dosage forms.

摘要

报道了采用高压液相色谱(HPLC)法测定氟哌啶醇在5%葡萄糖注射液中的稳定性。使用市售氟哌啶醇注射液配制5%葡萄糖注射液中含氟哌啶醇10mg/dl的溶液。该溶液在24℃下储存,一半置于琥珀色玻璃瓶中,一半置于塑料袋中。分别在第0、1、7、14和38天进行测定。对市售剂型(注射液、口服浓缩液和片剂)的氟哌啶醇所制溶液进行测定,以验证HPLC法对氟哌啶醇定量分析的准确性。在24℃下,无论是储存在琥珀色玻璃瓶还是塑料袋中,氟哌啶醇在38天内效力均无损失。储存在塑料袋中的溶液中,对羟基苯甲酸甲酯和对羟基苯甲酸丙酯(存在于市售氟哌啶醇注射液中)有大量损失。氟哌啶醇的氧化产物不干扰测定,HPLC法能准确测定市售剂型所制溶液中的氟哌啶醇。结果表明,5%葡萄糖注射液中含氟哌啶醇10mg/dl至少在38天内是稳定的。虽然对羟基苯甲酸酯的损失并无实际重要性,但所建立的HPLC法能提供此信息,而先前使用的美国药典-国家处方集方法则不能。该测定法可用于定量分析市售剂型中的氟哌啶醇。

相似文献

1
Stability of haloperidol in 5% dextrose injection.氟哌啶醇在5%葡萄糖注射液中的稳定性。
Am J Hosp Pharm. 1982 Feb;39(2):292-4.
2
Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.盐酸多巴酚丁胺与盐酸维拉帕米在0.9%氯化钠注射液和5%葡萄糖注射液中的稳定性
Am J Hosp Pharm. 1984 Apr;41(4):686-9.
3
Stability of levodopa in 5% dextrose injection at pH 5 or 6.左旋多巴在pH值为5或6的5%葡萄糖注射液中的稳定性。
Am J Hosp Pharm. 1986 Jul;43(7):1726-8.
4
Stability of doripenem in vitro in representative infusion solutions and infusion bags.多利培南在代表性输液溶液和输液袋中的体外稳定性。
Clin Ther. 2008 Nov;30(11):2075-87. doi: 10.1016/j.clinthera.2008.11.013.
5
Stability of cefazolin sodium in peritoneal dialysis solutions.头孢唑林钠在腹膜透析液中的稳定性。
Am J Hosp Pharm. 1991 Feb;48(2):291-2.
6
Stability of esmolol hydrochloride in intravenous solutions.盐酸艾司洛尔在静脉注射液中的稳定性。
Am J Hosp Pharm. 1994 Nov 1;51(21):2693-6.
7
Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.酒石酸美托洛尔在5%葡萄糖注射液或0.9%氯化钠注射液中的稳定性。
Am J Hosp Pharm. 1993 May;50(5):950-2.
8
Stability of lidocaine hydrochloride in 5% dextrose injection in plastic bags.
Am J Hosp Pharm. 1981 Nov;38(11):1745-7.
9
Stability of ciprofloxacin injection in peritoneal dialysis solutions.环丙沙星注射液在腹膜透析液中的稳定性。
Am J Hosp Pharm. 1994 Feb 1;51(3):373-7.
10
Stability of sulfadiazine oral liquids prepared from tablets and powder.
J Pharm Pharm Sci. 2004 Apr 21;7(1):84-7.

引用本文的文献

1
Stability of mixtures of ondansetron and haloperidol stored in infusors at different temperatures.不同温度下储存在输液器中的昂丹司琼与氟哌啶醇混合物的稳定性。
Eur J Hosp Pharm. 2018 Oct;25(e2):e134-e138. doi: 10.1136/ejhpharm-2017-001412. Epub 2018 Jan 27.
2
Stability and compatibility of ondansetron with haloperidol in parenteral admixtures.昂丹司琼与氟哌啶醇在肠外混合液中的稳定性及相容性
Eur J Hosp Pharm. 2018 Jul;25(4):200-203. doi: 10.1136/ejhpharm-2016-001200. Epub 2017 Apr 13.